Multivariable analysis of associations of baseline characteristics and clinical outcomes
Characteristic . | No. . | OS . | DFS . | ||||
---|---|---|---|---|---|---|---|
Adjusted HR* . | 95% CI . | P* . | Adjusted HR* . | 95% CI . | P* . | ||
Sex | |||||||
Male | 65 | Ref | .005 | Ref | .008 | ||
Female | 45 | 0.37 | 0.18-0.74 | 0.41 | 0.21-0.79 | ||
Donor type | |||||||
MRD | 51 | Ref | <.001 | Ref | <.001 | ||
MUD 10/10 | 44 | 1.43 | 0.70-2.95 | 2.38 | 1.21-4.68 | ||
mMUD | 15 | 8.32 | 3.47-19.93 | 6.30 | 2.69-14.74 | ||
MF | |||||||
Primary | 58 | Ref | .094 | Ref | .024 | ||
Secondary | 52 | 0.56 | 0.29-1.10 | 0.48 | 0.26-0.91 | ||
Cytogenetics | |||||||
Favorable | 67 | Ref | .001 | Ref | .008 | ||
Unfavorable | 24 | 2.31 | 1.05-5.07 | 1.39 | 0.66-2.94 | ||
VHR | 15 | 4.19 | 1.93-9.13 | 3.14 | 1.53-6.47 | ||
MIPSS70+ v2.0 classification† | |||||||
Intermediate risk | 11 | 0.29 | 0.04-2.26 | <.001 | 0.24 | 0.03-1.91 | <.001 |
High risk | 47 | Ref | Ref | ||||
VHR | 35 | 5.05 | 2.39-10.70 | 3.87 | 1.90-7.88 |
Characteristic . | No. . | OS . | DFS . | ||||
---|---|---|---|---|---|---|---|
Adjusted HR* . | 95% CI . | P* . | Adjusted HR* . | 95% CI . | P* . | ||
Sex | |||||||
Male | 65 | Ref | .005 | Ref | .008 | ||
Female | 45 | 0.37 | 0.18-0.74 | 0.41 | 0.21-0.79 | ||
Donor type | |||||||
MRD | 51 | Ref | <.001 | Ref | <.001 | ||
MUD 10/10 | 44 | 1.43 | 0.70-2.95 | 2.38 | 1.21-4.68 | ||
mMUD | 15 | 8.32 | 3.47-19.93 | 6.30 | 2.69-14.74 | ||
MF | |||||||
Primary | 58 | Ref | .094 | Ref | .024 | ||
Secondary | 52 | 0.56 | 0.29-1.10 | 0.48 | 0.26-0.91 | ||
Cytogenetics | |||||||
Favorable | 67 | Ref | .001 | Ref | .008 | ||
Unfavorable | 24 | 2.31 | 1.05-5.07 | 1.39 | 0.66-2.94 | ||
VHR | 15 | 4.19 | 1.93-9.13 | 3.14 | 1.53-6.47 | ||
MIPSS70+ v2.0 classification† | |||||||
Intermediate risk | 11 | 0.29 | 0.04-2.26 | <.001 | 0.24 | 0.03-1.91 | <.001 |
High risk | 47 | Ref | Ref | ||||
VHR | 35 | 5.05 | 2.39-10.70 | 3.87 | 1.90-7.88 |